The Impact of Genetic Tests on Treatment and Surgical Decisions in Breast Cancer
Experts state that genetic tests directly shape patients' treatment processes, surgical choices, and the health monitoring of family members.
Prof. Dr. Deniz Arslan, Medical Oncology Specialist at Medicana International Istanbul Hospital, explained the critical role of genetic tests in treatment and surgical decisions for breast cancer patients.
The Importance of Genetic Tests
Prof. Dr. Deniz Arslan stated that genetic tests shape treatment and surgical decisions in appropriate patients, in addition to determining future cancer risk.
It was emphasized that performing the right test on the right patient at the right time can change both the treatment and the family's future.
Hereditary Risk Assessment
Age at diagnosis, tumor characteristics, and family history of cancer provide important information in hereditary risk assessment.
However, the fact that family history cannot always be fully known can lead to hereditary risk being overlooked.
Treatment Planning and Surgery
Alterations in genes such as BRCA1 or BRCA2 play a role in evaluating systemic treatment options and the surgical approach.
Genetic tests not only predict future risks but also produce significant results in the current treatment plan.
Monitoring for Family Members
The detected inherited gene alterations are associated with types such as ovarian, pancreatic, and prostate cancer, as well as breast cancer.
Performing targeted tests on appropriate family members allows individuals carrying the risk to be monitored at an earlier age.